QSant

15 to 40%
of kidney transplants result in rejection

~10%
of kidney transplants every year are
re-transplants in patients with graft loss

QSant™ sets a new standard for non-invasive assessment of kidney transplant rejection

BIOMARKERS:

  • Total Protein
  • cfDNA
  • m-cfDNA
  • CXCL10
  • Clusterin
  • Creatinine
NephroSant Personal Q-Score
PERSONAL Q-SCORE™

Q-Score

QSant Clinical Validation Papers

Clinical validation of a non-invasive, spot urine-based transplant rejection test that provides indication of risk of rejection earlier than standard-of-care tests.

601 samples
DOWNLOAD STM PAPER

PUBLISHED: 18 MARCH 2020

Development, validation, and clinical utility of a urinary Q-Score for the detection of acute rejection in adult and pediatric renal transplant patients

223 samples
DOWNLOAD MDPI PAPER

PUBLISHED: 22 JULY 2020